HCC827 Cells

HCC827 is a human non-small cell lung cancer cell line derived from the lung adenocarcinoma of a middle-aged female patient. These cells exhibit an epithelial morphology and are often used in research related to the epidermal growth factor receptor (EGFR). HCC827 cells are particularly noted for their sensitivity to tyrosine kinase inhibitors (TKIs), specifically those targeting EGFR mutations. This characteristic makes them a valuable model for studying the molecular mechanisms of lung cancer responsiveness to EGFR inhibitors, as well as for testing the efficacy of new therapeutic agents targeting EGFR-dependent pathways. The cell line is also used to explore the mechanisms of acquired resistance to targeted therapies, which is a significant challenge in the treatment of lung cancer. Studies utilizing HCC827 cells have contributed to a better understanding of the genetic and epigenetic alterations that confer resistance to EGFR inhibitors. These findings have implications for the development of strategies to overcome resistance and improve treatment outcomes in lung cancer patients. Furthermore, the HCC827 cell line serves as a tool for investigating the broader cellular and molecular landscape of lung adenocarcinoma, including studies on cell signaling, tumor microenvironment, and cancer metastasis.